From Design to Implementation of SARS-CoV-2 Diagnostic Testing

DATE:  July 8, 2020

TIME:  10:00 am PDT

Since it was first detected in Wuhan, China, in 2019, the novel coronavirus SARS-CoV-2 and the disease it causes, COVID-19, have spread rapidly across the globe. Slowing the spread of the disease relies on social distancing measures as well as widespread and rapid diagnostic testing. This webinar will discuss design and development of the SARS CoV-2 diagnostic assay as well as review different strategies on the implementation of SARS-CoV-2 molecular testing under FDA Emergency Use Authorization only (EUA) in a US Integrated Hospital Delivery Network (IDN).

Learning Objectives:

•  Understand Important assay features to consider during design and development of SARS CoV-2 assay

• Review challenges and successes during implementation and scale up of SARS-CoV-2 Testing

• Evaluate different applications of SARS-CoV-2 PCR results to understand disease status and progression

Webinars will be available for unlimited on-demand viewing after live event.